NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Tuberculosis



New tuberculosis study findings reported from N. Harada and co-authors



August 26th, 2008

In this recently published article, scientists in Kiyose, Japan conducted a study "To compare the sensitivity and the specificity of the QuantiFERON (R)-TB Gold (QFT-G) and QuantiFERON (R)-TB Gold In Tube (QFT-GIT) diagnostic tests for Mycobacterium tuberculosis infection. One-hundred patients with culture and/or PCR confirmed M. tuberculosis infection and 168 volunteers with no risk factors for M. tuberculosis infection were tested to estimate sensitivity and specificity, respectively."

"Analysis of data from the tuberculosis (TB) patients with valid results found the sensitivity of QFT-GIT (92.6%, 87/94) to be significantly higher than that for the QFT-G test...


Source: TB & Outbreaks Week (2008-08-26)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login